Skip to Content

Therapeutic Solutions International Inc TSOI

Morningstar Rating
$0.00 0.00 (5.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TSOI is trading at a 66% discount.
Price
$0.00
Fair Value
$7.67
Uncertainty
Extreme
1-Star Price
$8.75
5-Star Price
$7.58
Economic Moat
Ybjv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TSOI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.00
Market Cap
$3.67 Mil
Volume/Avg
28.3 Mil / 10.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
39.66
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) and Lung Pathology (LP).
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
3

Valuation

Metric
TSOI
Price/Earnings (Normalized)
Price/Book Value
3.03
Price/Sales
39.66
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TSOI
Quick Ratio
0.05
Current Ratio
0.09
Interest Coverage
−4.83
Quick Ratio
TSOI

Profitability

Metric
TSOI
Return on Assets (Normalized)
−64.30%
Return on Equity (Normalized)
−164.96%
Return on Invested Capital (Normalized)
−80.91%
Return on Assets
TSOI
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRPyv$537.7 Bil
VRTX
Vertex Pharmaceuticals IncQxtskmn$108.4 Bil
REGN
Regeneron Pharmaceuticals IncKctwcv$104.6 Bil
MRNA
Moderna IncMplyv$33.4 Bil
ARGX
argenx SE ADRThhtj$23.7 Bil
BNTX
BioNTech SE ADRBycjx$22.0 Bil
ALNY
Alnylam Pharmaceuticals IncDjjzp$19.5 Bil
BMRN
Biomarin Pharmaceutical IncYbyrtpy$16.7 Bil
RPRX
Royalty Pharma PLC Class AWqhhk$14.0 Bil
INCY
Incyte CorpFzdbvwq$13.5 Bil

Sponsor Center